United Therapeutics Corp. (UTHR)
541.70
-29.68
(-5.19%)
USD |
NASDAQ |
Oct 02, 16:00
537.12
-4.58
(-0.85%)
After-Hours: 20:00
United Therapeutics Market Cap : 23.12B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 23.12B |
| October 01, 2026 | 24.38B |
| September 30, 2026 | 23.13B |
| September 29, 2026 | 20.55B |
| September 28, 2026 | 20.72B |
| September 25, 2026 | 20.29B |
| September 24, 2026 | 20.15B |
| September 23, 2026 | 20.89B |
| September 22, 2026 | 21.24B |
| September 21, 2026 | 21.04B |
| September 18, 2026 | 21.11B |
| September 17, 2026 | 21.22B |
| September 16, 2026 | 21.27B |
| September 15, 2026 | 21.35B |
| September 14, 2026 | 21.45B |
| September 11, 2026 | 21.22B |
| September 10, 2026 | 21.50B |
| September 09, 2026 | 21.63B |
| September 08, 2026 | 21.25B |
| September 04, 2026 | 20.81B |
| September 03, 2026 | 20.92B |
| September 02, 2026 | 21.00B |
| September 01, 2026 | 21.88B |
| August 31, 2026 | 21.78B |
| August 28, 2026 | 22.00B |
| Date | Value |
|---|---|
| August 27, 2026 | 22.53B |
| August 26, 2026 | 22.05B |
| August 25, 2026 | 22.13B |
| August 24, 2026 | 21.89B |
| August 21, 2026 | 21.90B |
| August 20, 2026 | 22.23B |
| August 19, 2026 | 22.58B |
| August 18, 2026 | 22.12B |
| August 17, 2026 | 21.70B |
| August 14, 2026 | 21.33B |
| August 13, 2026 | 21.39B |
| August 12, 2026 | 21.84B |
| August 11, 2026 | 22.00B |
| August 10, 2026 | 22.60B |
| August 07, 2026 | 23.00B |
| August 06, 2026 | 22.74B |
| August 05, 2026 | 22.15B |
| August 04, 2026 | 22.14B |
| August 03, 2026 | 22.03B |
| July 31, 2026 | 21.82B |
| July 30, 2026 | 22.17B |
| July 29, 2026 | 22.12B |
| July 28, 2026 | 22.07B |
| July 27, 2026 | 22.26B |
| July 24, 2026 | 22.28B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Liquidia Corp. | 2.552B |
| MannKind Corp. | 1.178B |
| Insmed, Inc. | 24.26B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
Market Cap Related Metrics
| PE Ratio | 19.38 |
| PS Ratio | 8.054 |
| PEG Ratio | 2.115 |
| Price to Book Value | 3.612 |
| Price to Free Cash Flow | 23.43 |
| Price | 541.70 |
| Earnings Yield | 5.16% |
| PEGY Ratio | 2.115 |
| Operating PE Ratio | 18.10 |
| Normalized PE Ratio | 20.76 |